New Data Show Rexahn's Supinoxin(TM) Decreases the Migration of Human Triple Negative Breast Cancer Cells in a Metastatic Cancer Model Apr 21, 2015
Rexahn Identifies RX-3117 Biomarker & Presents Data at the 2015 American Association for Cancer Research Annual Meeting Apr 20, 2015
Rexahn Pharmaceuticals to Present Data on RX-3117 and Supinoxin(TM) at the 2015 American Association for Cancer Research Annual Meeting Apr 13, 2015
Rexahn Pharmaceuticals to Present at the 12th Annual BIO Asia International Conference in Tokyo, Japan Mar 18, 2015
Rexahn Pharmaceuticals Reports Fourth Quarter and Full-Year 2014 Financial Results and Pipeline Update Mar 17, 2015
Rexahn Pharmaceuticals to Present at the BIO-Europe Spring(R) 2015 Conference in Paris, France Mar 4, 2015
Rexahn Pharmaceuticals to Present at the ROTH Capital Partners 27th Annual Growth Stock Conference Mar 2, 2015
Rexahn Pharmaceuticals to Present at the 3rd Annual Sachs Cancer Bio Partnering & Investment Forum in New York Feb 18, 2015
Rexahn Pharmaceuticals Announces the Publication of Preclinical Data for Supinoxin(TM) (RX-5902) Demonstrating Mechanism of Action Feb 9, 2015